Triple Negative Breast Cancer Day is an annual global event on March 3. This is a day for a global awareness and grassroots fundraising aimed at helping to eradicate triple-negative breast cancer and celebrating the courage and strength of triple negative breast cancer patients and survivors.
Triple negative breast cancer gets its name from the fact that it tests negative for three types of receptors, or proteins, that appear in and fuel other types of breast cancer: estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2).
There are no targeted therapies for treating triple negative breast cancer. Instead, it is treated with chemotherapy, surgery, and radiation.
About 10 to 20 percent of all breast cancer diagnoses, or between 2630 and 5260 in Canada annually, are triple negative.
Researchers are beginning to identify alternative pathways and targets that could be used in the treatment of triple-negative breast cancer.
On this Triple Negative Breast Cancer Day, the Canadian Breast Cancer Network continues to stand in support of all Canadians affected by triple-negative breast cancer to promote increased awareness and encourage the development of new technologies and expanded treatment options for all women living with this disease.